SCHEMBL10128067

SCHEMBL10128067

Cc1cccc2c1oc1c(-c3ccc(-c4nnc5c6ccccc6ccn45)cc3)cccc12

nearest known ligand 0.36

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 5/20 0.36
KDM4E B2RXH2 3/20 0.36
POLB P06746 2/20 0.36
HSD17B10 Q99714 2/20 0.36
HPGD P15428 1/20 0.36
TSHR P16473 1/20 0.36
MAPT P10636 5/20 0.36
ENPP3 O14638 1/20 0.36
ENPP1 P22413 1/20 0.36
TP53 P04637 3/20 0.35
ADORA3 P0DMS8 2/20 0.34
ADORA2A P29274 1/20 0.34
ADORA1 P30542 1/20 0.34
KMT2A Q03164 2/20 0.33
RXFP1 Q9HBX9 1/20 0.33
CYP2A6 P11509 1/20 0.33
RAB9A P51151 2/20 0.32
SMN1; SMN2 Q16637 2/20 0.32
HCRTR1 O43613 1/20 0.32
ALOX15 P16050 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL10128088 0.92 PRKDC (0.37) ALDH1A1KDM4EPOLBHSD17B10HPGD
SCHEMBL10128029 0.87 ALOX5 (0.44) ALDH1A1KDM4EHSD17B10HPGDMAPT
SCHEMBL10128044 0.86 ALOX5 (0.43) ALDH1A1KDM4EHSD17B10HPGDMAPT
SCHEMBL10128076 0.84 MAPT (0.36) ALDH1A1KDM4EPOLBHSD17B10HPGD
SCHEMBL10128045 0.83 ALOX5 (0.40) ALDH1A1KDM4EHSD17B10HPGDMAPT
SCHEMBL10128135 0.81 ALOX5 (0.43) ALDH1A1KDM4EPOLBHSD17B10HPGD
SCHEMBL10128046 0.81 ALOX5 (0.46) ALDH1A1MAPT
SCHEMBL10128133 0.80 ALOX5 (0.42) ALDH1A1POLBTSHRMAPTTP53
SCHEMBL10127919 0.80 ALDH1A1 (0.36) ALDH1A1KDM4EPOLBHSD17B10HPGD
SCHEMBL10128093 0.80 POLB (0.34) ALDH1A1KDM4EPOLBHSD17B10HPGD

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-9034486-B2 Triazole derivative, heterocyclic compound, light-emitting element, light-emitting device, electronic device and lighting device SEMICONDUCTOR ENERGY LABORATORY CO., LTD (JP) 2015-05-19 US disclosed
US-9034486-B2 Triazole derivative, heterocyclic compound, light-emitting element, light-emitting device, electronic device and lighting device SEMICONDUCTOR ENERGY LABORATORY CO., LTD (JP) 2015-05-19 US disclosed
WO-2012017842-A1 TRIAZOLE DERIVATIVE, HETEROCYCLIC COMPOUND, LIGHT-EMITTING ELEMENT, LIGHT-EMITTING DEVICE, ELECTRONIC DEVICE AND LIGHTING DEVICE SEMICONDUCTOR ENERGY LABORATORY CO., LTD. (JP) 2012-02-09 WO disclosed
US-20120025697-A1 Triazole Derivative, Heterocyclic Compound, Light-Emitting Element, Light-Emitting Device, Electronic Device and Lighting Device SEMICONDUCTOR ENERGY LABORATORY CO., LTD. 2012-02-02 US disclosed
US-20120025697-A1 Triazole Derivative, Heterocyclic Compound, Light-Emitting Element, Light-Emitting Device, Electronic Device and Lighting Device SEMICONDUCTOR ENERGY LABORATORY CO., LTD. 2012-02-02 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20120025697-A1 Triazole Derivative, Heterocyclic Compound, Light-Emitting Element, Light-Emitting Device, Electronic Device and Lighting Device HTR3D, KCNQ4, KCNQ3 ALDH1A1 1032/4885KDM4E 2008/4885POLB 3317/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.